Healthcare - Drug Manufacturers - General - NASDAQ - US
$ 88.4
-4.03 %
$ 110 B
Market Cap
982.22
P/E
INCOME STATEMENT
27.1 B
REVENUE
7.6 B
OPERATING INCOME
5.61 B
NET INCOME
EFFICIENCY
Earnings Waterfall
Gilead Sciences, Inc.
| Revenue | 27.1 B |
| Cost Of Revenue | 5.97 B |
| Gross Profit | 21.1 B |
| Operating Expenses | 13 B |
| Operating Income | 7.6 B |
| Other Expenses | 1.99 B |
| Net Income | 5.61 B |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | Dec-2008 | Dec-2007 | Dec-2006 | Dec-2005 | Dec-2004 | Dec-2003 | Dec-2002 | Dec-2001 | Dec-2000 | Dec-1999 | Dec-1998 | Dec-1997 | Dec-1996 | Dec-1995 | Mar-1995 | Mar-1993 | Mar-1992 | Mar-1991 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||||||||||||||||||||||||||
| Revenue | 27 116.0 | 27 281.0 | 27 305.0 | 24 689.0 | 22 449.0 | 22 127.0 | 26 107.0 | 30 390.0 | 32 639.0 | 24 890.0 | 11 201.7 | 9 702.5 | 8 385.4 | 7 949.4 | 7 011.4 | 5 335.8 | 4 230.0 | 3 026.1 | 2 028.4 | 1 324.6 | 867.9 | 466.8 | 233.8 | 195.6 | 169.0 | 32.6 | 40.0 | 33.4 | 2.7 | 4.1 | 4.2 | 2.8 | 1.3 |
| GROSS PROFIT | |||||||||||||||||||||||||||||||||
| Cost Of Revenue | 5 968.0 | 5 657.0 | 6 601.0 | 4 572.0 | 4 675.0 | 4 853.0 | 4 371.0 | 4 261.0 | 4 006.0 | 3 788.0 | 2 858.5 | 2 471.4 | 2 124.4 | 1 869.9 | 1 595.6 | 1 127.2 | 768.8 | 433.3 | 260.3 | 166.6 | 112.7 | 69.7 | 43.8 | 21.5 | 16.9 | (2.2) | (1.8) | (3.6) | (3.2) | (2.8) | (1.7) | (1.0) | (0.8) |
| Gross Profit | 21 148.0 | 21 624.0 | 20 704.0 | 20 117.0 | 17 774.0 | 17 274.0 | 21 736.0 | 26 129.0 | 28 633.0 | 21 102.0 | 8 343.2 | 7 231.2 | 6 261.0 | 6 079.5 | 5 415.8 | 4 208.5 | 3 461.3 | 2 592.8 | 1 768.1 | 1 158.0 | 755.2 | 397.1 | 190.0 | 174.1 | 152.1 | 34.8 | 41.8 | 37.0 | 5.9 | 6.9 | 5.9 | 3.8 | 2.1 |
| OPERATING INCOME | |||||||||||||||||||||||||||||||||
| Operating Expenses | 13 013.0 | 10 650.0 | 10 609.0 | 10 190.0 | 13 487.0 | 9 074.0 | 7 612.0 | 8 496.0 | 6 440.0 | 5 837.0 | 3 819.2 | 3 221.0 | 2 471.1 | 2 117.3 | 1 886.6 | 1 530.0 | 1 296.8 | 957.5 | 657.0 | 526.3 | 425.2 | 316.1 | 310.7 | 226.4 | 203.8 | 109.1 | 87.7 | 73.1 | 37.9 | 36.4 | 24.1 | 10.1 | 6.9 |
| Selling, General and Administrative Expenses | 6 090.0 | 5 673.0 | 5 246.0 | 5 151.0 | 4 381.0 | 4 056.0 | 3 878.0 | 3 398.0 | 3 426.0 | 2 983.0 | 1 699.4 | 1 461.0 | 1 242.0 | 1 044.4 | 946.7 | 797.3 | 705.7 | 573.7 | 379.2 | 302.8 | 250.2 | 181.3 | 125.1 | 82.8 | 78.3 | 31.0 | 25.5 | 26.7 | 34.7 | 7.6 | 22.4 | 9.1 | 6.1 |
| Research and Development Expenses | 6 923.0 | 4 977.0 | 5 363.0 | 5 039.0 | 9 106.0 | 5 018.0 | 3 734.0 | 5 098.0 | 3 014.0 | 2 854.0 | 2 119.8 | 1 759.9 | 1 229.2 | 1 072.9 | 939.9 | 721.8 | 591.0 | 383.9 | 277.7 | 223.6 | 164.9 | 134.8 | 185.6 | 131.6 | 112.9 | 75.3 | 59.2 | 41.9 | 0 | 26.0 | 0 | 0 | 0 |
| Operating Income | 7 605.0 | 7 330.0 | 7 406.0 | 7 029.0 | 4 287.0 | 8 200.0 | 14 124.0 | 17 633.0 | 22 193.0 | 15 265.0 | 4 524.0 | 4 010.2 | 3 789.8 | 3 962.2 | 3 529.2 | 2 678.5 | 2 164.5 | (758.8) | 1 111.1 | 631.7 | (158.7) | 81.0 | (120.7) | (52.3) | (51.7) | (74.3) | (45.9) | (36.1) | (32.0) | (29.5) | (18.2) | (6.3) | (4.8) |
| PRE-TAX INCOME | |||||||||||||||||||||||||||||||||
| Interest Income Expense | 944.0 | 935.0 | 1 001.0 | 984.0 | 995.0 | 1 077.0 | 1 118.0 | 964.0 | 688.0 | 412.0 | 306.9 | 360.9 | 205.4 | 109.0 | 69.7 | 12.1 | (105.8) | 4 667.6 | (50.7) | (37.9) | 996.3 | 23.7 | (343.6) | 6.1 | 37.7 | (18.4) | (18.3) | (15.0) | (5.2) | (4.2) | (4.3) | (1.9) | (1.6) |
| Total Other Income | (746.0) | (1 516.0) | 872.0 | (2 402.0) | 873.0 | (401.0) | (595.0) | (536.0) | (534.0) | (409.0) | (315.8) | (398.2) | (138.8) | (48.7) | (27.3) | (5.8) | 105.8 | 120.5 | 50.7 | 24.7 | (8.9) | (7.6) | 178.1 | 10.4 | (13.9) | 22.4 | (0.5) | 15.0 | 5.2 | 9.9 | 4.3 | 1.9 | 0.8 |
| Pre-Tax Income | 6 859.0 | 5 814.0 | 8 278.0 | 1 669.0 | 5 160.0 | 7 799.0 | 13 529.0 | 17 097.0 | 21 659.0 | 14 856.0 | 4 208.2 | 3 612.0 | 3 651.0 | 3 913.5 | 3 502.0 | 2 734.4 | 2 270.3 | (638.2) | 1 161.8 | 656.4 | (167.5) | 73.4 | 57.4 | (41.9) | (65.6) | (55.9) | (27.6) | (21.1) | (26.8) | (25.3) | (13.9) | (4.4) | (4.0) |
| NET INCOME | |||||||||||||||||||||||||||||||||
| Tax Provision | 1 247.0 | 1 248.0 | 2 077.0 | 1 580.0 | (204.0) | 2 339.0 | 8 885.0 | 3 609.0 | 3 553.0 | 2 797.0 | 1 150.9 | 1 038.4 | 861.9 | 1 023.8 | 876.4 | 723.3 | 655.0 | 551.8 | 347.9 | 207.1 | (95.5) | 1.3 | 4.1 | 1.2 | 0.9 | (36.6) | (36.2) | (29.4) | (9.8) | (8.0) | (8.4) | (3.7) | (1.6) |
| Net Income | 5 665.0 | 4 592.0 | 6 225.0 | 89.0 | 5 386.0 | 5 455.0 | 4 628.0 | 13 501.0 | 18 108.0 | 12 101.0 | 3 074.8 | 2 591.6 | 2 803.6 | 2 901.3 | 2 635.8 | 2 011.2 | 1 615.3 | (1 190.0) | 813.9 | 449.4 | (72.0) | 72.1 | 52.3 | (56.8) | (66.5) | (56.1) | (28.0) | (21.7) | (27.4) | (25.7) | (14.1) | (4.5) | (4.0) |
| EPS | 4.54 | 3.66 | 4.96 | 0.0708 | 4.24 | 4.2 | 3.54 | 10.1 | 12.4 | 7.95 | 2.01 | 1.71 | 1.81 | 1.7 | 1.46 | 1.09 | 0.87 | 0.65 | 0.45 | 0.26 | 0.0448 | 0.0463 | 0.035 | 0.039 | 0.0485 | 0.0427 | 0.0269 | 0.0244 | 0.0402 | 0.0431 | 0.0275 | 0.0125 | 0.0131 |